MedPath

COUREUR Study Myocardial Inflammation in Cyclist Part 1

Not Applicable
Completed
Conditions
Myocardial Inflammation
Registration Number
NCT04940650
Lead Sponsor
Jessa Hospital
Brief Summary

The study will evaluate myocardial inflammation in cyclists after high intense and sustained exercise. Our hypothesis is that strenuous exercise in recreational cyclists may be associated with myocardial inflammation. Myocardial fibrosis in asymptomatic athletes is associated with life-threatening arrhythmic events and sudden death. Although myocarditis seems to be the most likely underlying cause, it remains unclear if strenuous and sustained physical exercise can cause myocardial inflammation with development of myocyte necrosis and possibly myocardial fibrosis in athletes.

Nineteen recreational cyclists performing "L'ETAPE DU TOUR (EDT) de France" a cycling ride (175 km, 3600 m of positive altitude difference) on July 4 2021 will be included in this study.

In part 1 of the study, each participant will complete a detailed questionnaire detailing their training history and an echocardiography at rest will be performed. All participants will have exercise testing approximately 1 week before the EDT stage to set aerobic and anaerobic gas exchange thresholds, as well as VO2max.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
19
Inclusion Criteria
  • Recreational cyclists performing the 'étape du tour (EDT) de France 2021 ride
Exclusion Criteria
  • presence of pre-existing cardiovascular or pulmonary diseases, hypertension, diabetes, peripheral vascular diseases, any inflammatory or auto-immune diseases and the intake of anti-inflammatory drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
DETECTION OF MYOCARDIAL INFLAMMATION IN CYCLISTS AFTER STRENUOUS EXERCISE: A PILOT STUDY PART 1approximately 1 week before the strenuous exercise

Assessments of weight (in kilograms) and heigth (in meters) to determine VO2 max (ml/kg/min)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hasselt University

🇧🇪

Hasselt, Belgium

Jessa Hospital

🇧🇪

Hasselt, Belgium

Hasselt University
🇧🇪Hasselt, Belgium
© Copyright 2025. All Rights Reserved by MedPath